Literature DB >> 25895871

How nanoparticles interact with cancer cells.

Abdullah Syed1, Warren C W Chan.   

Abstract

There are currently no nanoparticle formulations that optimally target diseased cells in the body. A small percentage of nanoparticles reach these cells and most accumulate in cells of the mononuclear phagocytic system. This chapter explores the interactions between nanoparticles and cells that may explain the causes for off-target accumulation of nanoparticles. A greater understanding of the nanoparticle-cellular interactions will lead to improvements in particle design for improved therapeutic outcome.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25895871     DOI： 10.1007/978-3-319-16555-4_10

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


  4 in total

1.  Angiosuppressive effects of bio-fabricated silver nanoparticles synthesis using Clitoria ternatea flower: an in vitro and in vivo approach.

Authors:  Balaji Kyathegowdanadoddi Srinivas; Madhu Chakkere Shivamadhu; Kiran Kumar Siddappaji; Dharmappa Kattepura Krishnappa; Shankar Jayarama
Journal:  J Biol Inorg Chem       Date:  2019-09-19       Impact factor: 3.358

Review 2.  Nanoparticle Platforms for Antigen-Specific Immune Tolerance.

Authors:  Edward B Thorp; Christian Boada; Clarens Jarbath; Xunrong Luo
Journal:  Front Immunol       Date:  2020-05-20       Impact factor: 7.561

Review 3.  The Landscape of Nanovectors for Modulation in Cancer Immunotherapy.

Authors:  Simona-Ruxandra Volovat; Corina Lupascu Ursulescu; Liliana Gheorghe Moisii; Constantin Volovat; Diana Boboc; Dragos Scripcariu; Florin Amurariti; Cipriana Stefanescu; Cati Raluca Stolniceanu; Maricel Agop; Cristian Lungulescu; Cristian Constantin Volovat
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

4.  Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.

Authors:  Lingxi Xing; Qiusheng Shi; Kailiang Zheng; Ming Shen; Jing Ma; Fan Li; Yang Liu; Lizhou Lin; Wenzhi Tu; Yourong Duan; Lianfang Du
Journal:  Theranostics       Date:  2016-06-18       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.